SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

The iShares Silver Trust (SLV) is experiencing a historic surge, propelled by strong physical demand, notably from China, alongside rising industrial applications in AI and electric vehicles. This rally is generating intense community discussion, with many anticipating a significant short squeeze and the end of prolonged price suppression. However, others remain cautious, debating if the rapid ascent signifies a true repricing or an overextended, speculative move.

A SPAC III Acquisition Corp. is a blank check company. The company was created for the purpose of effecting a merger, asset acquisition, share purchase, reorganization or similar business combination. The company was founded on September 3, 2021 and is headquartered in Hong Kong.

A SPAC III Acquisition Corp. - Ordinary Shares - Class A

Alpha Capital Acquisition Co - Ordinary Shares - Class A

ASPC is currently experiencing extreme volatility and frequent trading halts, fueling a heated debate among investors. Bulls are driving a potential short squeeze, pointing to its low float and high borrow rates, while bears caution against a pump-and-dump, often referencing its nature as a Chinese SPAC. The community is actively discussing whether this momentum will lead to further parabolic gains or a rapid reversal, drawing parallels to other recent volatile low-float plays.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is heavily trending amid China's recent sanctions against the company, which many in the community interpret as a significant validation of its role as a critical U.S. defense contractor. This sentiment is amplified by the U.S. government's push to ban foreign-made drones, creating a clear market opportunity for Red Cat's Blue UAS-compliant platforms and anticipated large defense budgets for U.S.-manufactured small drones and unmanned surface vessels. Despite recent price fluctuations, discussion centers on the company's preparedness to meet increased demand through domestic production, fueling expectations for substantial contract awards.

GSI Technology, Inc. engages in the design, development and marketing of memory products primarily for the networking, and telecommunications markets. Its product includes Static Random Access Memory, or SRAM, which incorporated in networking and telecommunications equipment, such as routers, switches, wide area network infrastructure equipment, wireless base stations and network access equipment. It also offers services to the ongoing needs of the military, industrial, test and measurement equipment, automotive and medical markets for SRAMs .The company was founded by Lee-Lean Shu and Robert Yau in March 1995 and is headquartered in Sunnyvale, CA.

GSI Technology Inc

GSI Technology is trending due to its specialized AI chips, particularly the energy-efficient Gemini-II APU, which is gaining traction for edge computing in defense and drone applications. The stock is a focal point of intense community debate, with bulls highlighting recent academic validation and potential government contracts as key catalysts, while bears point to commercial struggles and fundamental technology concerns, fueling significant market volatility.

Zeta Global Holdings Corp. operates as a marketing technology software company, which engages in the provision of enterprises with consumer intelligence and marketing automation software. It enables its customers to target, connect and engage consumers through software that delivers marketing across all addressable channels, including email, social media, web chat, connected TV and video among others. The company was founded by David A. Steinberg and John Sculley on May 9, 2012 and is headquartered in New York, NY.

Zeta Global Holdings Corp - Ordinary Shares - Class A

Zeta Global Holdings Corp

Zeta Global is gaining significant attention, driven by anticipation for its upcoming CES 2026 showcase and the positive impact of its Marigold acquisition, alongside robust financial outlooks. The community widely regards it as an undervalued AI-powered marketing leader, expecting a substantial re-rating fueled by its innovative Athena platform and strategic first-party data capabilities.

First Majestic Silver Corp. engages in the production, development, exploration and acquisition of mineral properties. It owns and operates producing mines in México including the La Encantada Silver Mine, La Parrilla Silver Mine, San Martin Silver Mine, La Guitarra Silver Mine, Del Toro Silver Mine, Santa Elena Silver & Gold Mine, and San Dimas Silver & Gold Mine. The company was founded by Keith Neumeyer on September 26, 1979 and is headquartered in Vancouver, Canada.

First Majestic Silver Corporation

First Majestic Silver is trending amid an explosive global surge in silver prices, significantly higher in Asian markets, driven by severe supply deficits and robust industrial demand. Despite widespread frustration among investors over AG's stock lagging the metal's performance, the community firmly anticipates an inevitable, substantial catch-up rally for this pure-play silver miner.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

Greenwich LifeSciences (GLSI) is trending after announcing preliminary Phase 3 trial results for its GLSI-100 immunotherapy, showing an estimated 80% reduction in breast cancer recurrence within an open-label arm. This positive clinical update, coupled with reports of consistent insider buying and an extremely high cost-to-borrow rate, has ignited widespread community discussion about a potential short squeeze. Many investors hold strong conviction in GLSI's long-term valuation and significant strategic partnership or buyout potential within the biotech sector.

Starfighters Space, Inc. is engaged in the research and development of space flight, pilot training, and aeronautics programs. It operates the commercial fleet Lockhead F-104s. The company was founded by Rick Svetkoff on September 6, 2022 and is headquartered in Cape Canaveral, FL.

Starfighters Space Inc

Starfighters Space Inc. ($FJET) is experiencing extreme volatility and trending due to an exceptionally high borrow rate, sparking a heated short squeeze discussion. While proponents highlight its low float and unique Mach 2 aerospace technology with potential government contracts, critics point to significant dilution, lack of revenue, and classify it as a speculative 'pump and dump' within the currently active space sector.

Universe Pharmaceuticals, Inc. is a pharmaceutical company. The firm is focused on the manufacturing, marketing, sales, and distribution of traditional Chinese medicine derivative products. It also sells biomedical drugs, medical instruments, traditional Chinese medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. The company was founded on March 2, 1998 and is headquartered in Ji'an, China.

Universe Pharmaceuticals INC

Universe Pharmaceuticals (UPC) is trending sharply due to its extremely low float, fueling speculation of a massive short squeeze and rapid price movements including trading halts. The community is actively debating its potential for significant upside, with some highlighting its strong cash position, while others warn of a pump-and-dump in the volatile small-cap 'China floater' sector. This polarized sentiment is driving intense conversation around its dramatic market activity.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros is experiencing significant buzz following FDA approval of YARTEMLEA, establishing it as the first and only approved therapy for a life-threatening transplant complication. The community is highly optimistic about the company's de-risked financial standing, supported by a substantial licensing deal, anticipating strong revenue potential and further insights from an upcoming conference call. Many believe the stock remains undervalued, eyeing significant long-term growth and potential for a short squeeze.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ACADIA Pharmaceuticals Inc. $ACAD Holdings Decreased by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. trimmed its holdings in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) by 98.4% during the 3rd quarter, according to its most recent disclosure with...

ACADIA Pharmaceuticals (NASDAQ:ACAD) Hits New 1-Year High - Here's Why

ACADIA Pharmaceuticals (NASDAQ:ACAD) Hits New 1-Year High - Should You Buy...

Here's Why Acadia Pharmaceuticals (ACAD) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Hohimer Wealth Management LLC Decreases Position in ACADIA Pharmaceuticals Inc. $ACAD

Hohimer Wealth Management LLC decreased its position in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) by 26.6% during the 2nd quarter, according to its most recent disclosure with the SEC...

TFG Asset Management GP Ltd Has $3.48 Million Stake in ACADIA Pharmaceuticals Inc. $ACAD

TFG Asset Management GP Ltd raised its position in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) by 50.8% in the 2nd quarter, according to its most recent Form 13F filing with the...

Eventide Asset Management LLC Trims Holdings in ACADIA Pharmaceuticals Inc. $ACAD

Eventide Asset Management LLC decreased its holdings in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) by 14.6% in the second quarter, according to its most recent Form 13F filing...

Birchview Capital LP Sells 75,600 Shares of ACADIA Pharmaceuticals Inc. $ACAD

Birchview Capital LP lessened its position in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) by 28.7% in the second quarter, according to the company in its most recent 13F filing with the...

Acadia Pharmaceuticals Announces FDA Approval of DAYBUE STIX (trofinetide) for Oral Solution, a New Powder Formulation of Trofinetide for the Treatment of Rett Syndrome

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the U.S. Food and Drug Administration (FDA) has approved DAYBUE STIX (trofinetide) for oral solution, a dye- and preservative-free...

OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC Takes $928,000 Position in ACADIA Pharmaceuticals Inc. $ACAD

OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new position in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) during the second quarter, according...

Stifel Nicolaus Issues Positive Forecast for ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock Price

Stifel Nicolaus boosted their target price on shares of ACADIA Pharmaceuticals from $24.00 to $25.00 and gave the company a "hold" rating in a research note on Thursday...

ACADIA Pharmaceuticals, Inc. engages in the development and commercialization of medicines for central nervous system disorders. Its products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. The company was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA.

Current Price	$27.61
Prev Close	$27.87
Open	$27.87
Dividend Yield	0.00%
50-Day Moving Average	$24.22
Beta	0.95
Avg. Volume	1.6M
PE Ratio	17.93

52-Week High	$28.35
52-Week Low	$13.40
Market Capitalization	$4.72B
EPS (Annual)	$1.36
Price to Book	5.14
Revenue Per Employee	$1.46M
Enterprise Value/EBITDA	N/A

ACAD
Acadia Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ACAD News

ACADAcadia Pharmaceuticals Inc